Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Nature|August 5, 2026
The Virtual Tissues foundation model resolves spatial proteomics across scalesJohann Wenckstern, Eeshaan Jain, Benedikt von Querfurth, et al.
Cancers|August 14, 2025
Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor BoardTim Graf, Laura A Boos, Tarun Mehra, et al.
JMIR Human Factors|November 11, 2025
Collaborative Design and Development of a Patient-Centered Digital Health App for Supportive Cancer Care: Participatory StudySonia Difrancesco, Matthia Martina Bauert, Claude Lehmann, et al.
BMC Medical Informatics and Decision Making|October 31, 2018
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsFranziska Singer, Anja Irmisch, Nora C Toussaint, et al.
Cancer|August 9, 2024
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences studyVladimir Jolidon, Manuela Eicher, Isabelle Peytremann-Bridevaux, et al.
Clinical and Translational Radiation Oncology|November 24, 2022
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boardsSebastian M Christ, Philip Heesen, Urs J Muehlematter, et al.
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 13, 2026
Insights from a randomized controlled trial on a digital lifestyle intervention in non-small cell lung cancer survivors following inpatient rehabilitationManuel Weber, Anja M Raab, Kai-Uwe Schmitt, et al.
BMC Cancer|March 15, 2025
Comparative inpatient care of cancer vs. non-cancer patients in Switzerland during the national COVID-19 lockdown: a nationwide interrupted time series analysisLoïc Brunner, Anna Nicolet, Isabelle Peytremann-Bridevaux, et al.
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
Pageof 9